Finally, mutations in CTNNB1, which encodes β-catenin and is found in 70–80% of hepatoblastoma cases, further drive metabolic reprogramming by increasing the expression of pyruvate dehydrogenase kinase 1 (PDK1). This evidence concerns the gene PDK1 and hepatoblastoma.